Turn Therapeutics Inc.
TTRX
$3.53
$0.030.86%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -- | 260.40% | -26.11% | -- | |
| Total Receivables | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | |
| Prepaid Expenses | -- | 719.28% | -- | -- | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | |
| Total Current Assets | -- | 272.97% | -- | -- | |
|
|
|||||
| Total Current Assets | -- | 272.97% | -- | -- | |
| Net Property, Plant & Equipment | -- | 1,165.82% | -- | -- | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | -- | 24.13% | -- | -- | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | -- | 0.00% | -- | -- | |
| Total Assets | -- | 171.69% | -- | -- | |
|
|
|||||
| Total Accounts Payable | -- | 140.72% | -- | -- | |
| Total Accrued Expenses | -- | -- | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | -- | 404.65% | -- | -- | |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | |
| Total Other Current Liabilities | -- | -- | -- | -- | |
| Total Current Liabilities | -- | -43.25% | -- | -- | |
|
|
|||||
| Total Current Liabilities | -- | -43.25% | -- | -- | |
| Long-Term Debt | -- | -- | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | -- | -- | -- | -- | |
| Total Liabilities | -- | 36.79% | -- | -- | |
|
|
|||||
| Common Stock & APIC | -- | 10.64% | -- | -- | |
| Retained Earnings | -- | 2.15% | -- | -- | |
| Treasury Stock & Other | -- | -5,480.17% | -- | -- | |
| Total Common Equity | -- | 745.27% | -306.76% | -- | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | -- | -- | -- | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | |
|
|
|||||
| Total Common Equity | -- | 745.27% | -306.76% | -- | |
| Total Preferred Equity | -- | -- | -- | -- | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | -- | 745.27% | -306.76% | -- | |
|
|
|||||